The Anderson Perspective

As restaurants face economic headwinds, a new AI platform is empowering servers, enhancing guest experience, and promising to double bottom-line profits.

Shipping giant Frontline secures a massive capital-raising mandate, signaling bold moves ahead. What does this mean for global energy and investors?

Shirl Penney's CEO of the Year award signals a major shift. Discover how his model of 'Supported Independence' empowers advisors and reshapes finance.

Steward Partners' Florida expansion and CEO relocation highlight a new playbook for growth, focusing on community investment and employee ownership.

A new Texas BBQ joint opens in Airdrie, but it's more than a meal. It’s a story of strategic growth, local entrepreneurship, and building community.

Fleetworthy's award-winning platform unifies safety, compliance, and efficiency, setting a new standard for how commercial fleets operate. Here's why.

For years, patients with a rare skin lymphoma have lacked safe, effective first-line options. A novel light-activated therapy may soon change everything.

A Florida cancer network is revolutionizing treatment by bringing world-class clinical trials to local communities, accelerating lifesaving drug approvals.

A novel laser treatment for glaucoma is now in human trials, promising to lower eye pressure without a single cut. This could change millions of lives.

A strategic partnership combines advanced screening tech with the world's largest chemical library, promising to shorten the long road to finding new drugs.

AbbVie's breakthroughs at ASH 2025 show promise for tough blood cancers, offering durable responses, better safety, and finite treatment options.

For those with Primary Sclerosing Cholangitis, a cureless liver disease, a new drug shows potential to slow its relentless march. Here's what it means.

Politecnico di Milano launches a bold plan to tackle Europe's innovation gap and foster global talent, blending deep tech with a deep sense of social duty.

The launch of new, lower-cost drugs for osteoporosis and cancer could transform patient care and ease the strain on strained healthcare systems.

Accord Healthcare's launch of denosumab biosimilars promises to lower costs for critical osteoporosis and cancer treatments, fueling a wider revolution.

Millions with osteoporosis and cancer may soon access vital, lower-cost bone treatments as a wave of new biosimilars hits the market, promising major savings.

Accord Healthcare's launch of two new bone-health biosimilars promises to expand access for millions and ease financial strain on European health systems.

How an Indigenous corporation turned the tables on a mining giant, securing a landmark agreement that prioritizes cultural heritage and community benefit.

Politecnico di Milano is using science, diplomacy, and inclusive education to tackle global division and build a more innovative and equitable future.

A historic gift transfers LNP | LancasterOnline to a new nonprofit, a move designed to ensure local journalism thrives in an era of decline.